DR Monty Silverdale, a world leading consultant neurologist specialising in Parkinson’s disease and movement disorders, is to speak at Salford Care Organisation soon.

"Parkinson’s Disease Past Present and Future" is a free "Your Health Matters" talk taking place at Salford Royal Hospital, in the Humphrey Booth Lecture Theatre, Mayo Building on December 17, from 12noon to 1pm.

Dr Silverdale jointly runs Salford Royal’s Parkinson’s Disease Service. He has an active research interest, runs several Parkinson’s disease research studies, and is also on the World Parkinson’s Disease and Movement Disorder Society Evidence Based Committee, which produces international guidelines for the management of Parkinson’s disease.

Dr Silverdale said: “The last century has seen an enormous amount of research into Parkinson’s disease; we understand a great deal about the disorder and very good treatments are now available for many people with the condition.

"However, there is still a lot of work to do, and the next decade or two promises to be a very exciting time in Parkinson’s disease research. I will summarise this in my talk on Parkinson’s disease, past, present and future."

Salford Royal is run by Salford Care Organisation, which is one of four Care Organisations that make up The Northern Care Alliance NHS Group (NCA). The NCA brings together the Salford Royal and Pennine Acute trusts.

The event is one of a series of ‘Your Health Matters’ events, arranged to give the public and Salford Royal and Pennine Acute trust public members a greater insight into their local hospitals and the services they provide.

To book a place, contact the NCA membership team on 01706 517 302 or email membership@pat.nhs.uk.

For most of history, Parkinson disease was a rare disorder. In 1855, forty years after Dr James Parkinson described the disorder, approximately 22 people of 15 million in England and Wales died of the condition.

In 2019, roughly 150,000 individuals of 65 million in the United Kingdom are living with Parkinson’s disease. In less than two centuries, a rare disorder became common. The lifetime risk of Parkinson’s disease is now 1 in 15.